Our Projects

We work to help our clients achieve results that improve health systems, services, and, ultimately, people’s lives.


Refine Your Search

  • Reset
Found 232 results

Strengthening Immunization Service Delivery to Urban Poor Communities in the DRC

JSI, in collaboration with Gavi, the Vaccine Alliance, is assisting DRC's Ministry of Health/Expanded Program on Immunization (EPI) to develop and test strategies to help the immunization program to more effectively reach marginalized urban communities, with the ultimate goal of improving and maintaining high coverage rates among these communities. In the project's initial phase, JSI…


Rapid Immunization Skill Enhancement (RISE) in India

JSI is developing the Rapid Immunization Skills Enhancement (RISE) package with a capacity-building framework to cater to different levels of health personnel vis-a-vis program managers, medical officers, health workers, and mobilizers in India. JSI is implementing RISE under the Gavi Health System Strengthening Phase 2 Grant for India. The objective of RISE is to develop…


Building Healthy Cities

From 2017-2022, the USAID-funded Building Healthy Cities (BHC) project tested healthy urban planning approaches in Indore, India; Makassar, Indonesia; Kathmandu, Nepal; and Da Nang, Vietnam. Check out our virtual Project Accomplishments and Learning Exhibit to learn more about the project's work. BHC worked in partnership with Smart City initiatives and urban sector departments to build…


Ethiopia Health Management Information System Scale-Up Project (USAID)

Health management information systems and monitoring and evaluation (HMIS/M&E) are pivotal components of the Health Sector Transformation Plan (HSTP) of Ethiopia's Federal Ministry of Health (FMOH). Among the transformation agendas in the plan, Information Revolution gives paramount importance to maximizing the availability, accessibility, quality, and use of health information for informed decision-making at all levels…


Resilient and Responsive Health Organizations (HRSA)

JSI recognizes that high quality education, skills, and organizational capacity are paramount to building strong health systems. Yet many providers lack the skills to implement effective health programs, respond to health emergencies, and put learning into practice. Strengthening institutional capacity, while a daunting challenge in any setting, is further complicated in fragile states still recovering…


Zambia Supporting an AIDS-Free Era (USAID)

Despite significant progress towards reaching HIV epidemic control, Zambia continues to struggle with one of the highest HIV prevalence rates in the world: 12% of persons aged 15-49 are infected, with significant impact among women and men ages 25-34 as well as adolescent girls. The USAID SAFE: Supporting an AIDS-Free Era Program is a $142 million…


Subcutaneous DMPA Access Collaborative

Through the Access Collaborative, JSI is helping to expand contraceptive access and options. Launched in 2017, Access Collaborative, led by PATH and JSI, has supported more than 20 countries to facilitate planning for introduction and scale up of subcutaneous DMPA (DMPA-SC, marketed as Pfizer’s Sayana® Press). The Access Collaborative provides technical assistance to support the…


Vaccination Training for IOM/USRAP

The US Refugee Admissions Program (USRAP) vaccination program ensures the vaccination and health examination for the pre-departure of all US-bound refugees. To support the rapid expansion of the vaccination program, USRAP intake center staff across many countries must be trained quickly and thoroughly on proper vaccination practices. To help address this growing need, JSI is…


Advancing Partners & Communities, Sierra Leone

Even before Ebola hit Sierra Leone, the country had some of the world’s poorest health outcomes, especially in the area of maternal and child health. Ebola took a major toll on the health system—not only did more than 200 health workers die during the outbreak, but people stopped coming to health clinics. JSI's Advancing Partners…


Human Papillomavirus (HPV) Vaccine National Introduction

Globally, cervical cancer kills more than 250,000 women every year and 85 percent of these deaths occur in low- and middle-income countries. Two types of HPV cause 70 percent of cervical cancers and pre-cancerous cervical lesions. When provided to young girls between 9 and 14 years old, the HPV vaccine is the most cost-effective public health measure to prevent HPV and…


Partner with Us

We strive to build lasting relationships to produce better health outcomes for all.